| [February 15, 2012] |
 |
Research and Markets: Ceftaroline Fosamil - Comprehensive Patent Search: eliminate unnecessary risk with the industry benchmark in comprehensive patent information
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/6c6bb3/ceftaroline_fosami)
has announced the addition of the "Ceftaroline
Fosamil - Comprehensive Patent Search" report to their offering.
Eliminate unnecessary risk with the industry benchmark in comprehensive
patent information.
Pipeline Developer is a regularly updated, professional patent search
performed by our expert team, which not only identifies relevant
patents, but delivers categorisation and interpretation, all deliverd
by a convenient online interface.
The Pipeline Developer report covers Ceftaroline Fosamil
Ceftaroline Fosamil indications: Treatment of community acquired
pneumonia; Treatment of acute bacterial and skin structure infections
Ceftaroline Fosamil innovator: Takeda (Teflaro); Cerexa (Teflaro);
Forest Labs (Teflaro)
Imagine having your own team of pharmaceutical patent experts, at a
fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and legal
teams, Pipeline Developer minimises the risk of wasted developments or
legal action, by providing you with nothing less than the very best in
comprehensive patent information. Searched and analysed by highly
trained, dedicated staff using sophisticated searching techniques,
Pipeline Developer delivers results you can rely on. And that means your
staff can concentrate on how the patent landscape affects your business,
rather than trying to source reliable patent information.
Pipeline Developer features:
-
Comprehensive patent searching, covering the world's key territories
-
Identifies patents covering molecule, formulation, process, use,
combination and assay techniques
-
Patent identification, categorisation and interpretation
-
Grouped by patent family and assigned to development categories based
on Interpretation of key aspects of the patent claims
-
Manual filtration of patents not relevant to generic development
-
Updated on a monthly basis, including changes to patent families,
statuses, and litigation
-
Enables fast analysis and verification by hyper-linking to crucial
patent documents and national registers
For more information visit http://www.researchandmarkets.com/research/6c6bb3/ceftaroline_fosami
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
